Chronic obstructive pulmonary disease and sudden cardiac death: A systematic review

Trends in Cardiovascular Medicine

Volumn 26, Issue 7, 2016, Pages 606-613

  van den Berg, Marten E ^a   Stricker, Bruno H ^a,b   Brusselle, Guy G ^a,c   Lahousse, Lies ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Inspectorate of Health Care   (Netherlands)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cardiac arrest; COPD; Sudden cardiac death; Ventricular arrhythmia

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; MUSCARINIC RECEPTOR BLOCKING AGENT; TIOTROPIUM BROMIDE;

CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; ELECTROCARDIOGRAPHY; HEART ARREST; HEART RATE VARIABILITY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MEDLINE; META ANALYSIS (TOPIC); NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PUBLICATION; QT DISPERSION; QT INTERVAL; QTC INTERVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY ARREST; REVIEW; SEX DIFFERENCE; SHORT QT INTERVAL; SMOKING; SUDDEN CARDIAC DEATH; SURVIVAL; SYSTEMATIC REVIEW; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; FEMALE; MALE; MORTALITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTOR;

ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 84969731087     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2016.04.001     Document Type: Review

References (65)

1. [1] Leening, M.J., Siregar, S., Vaartjes, I., Bots, M.L., Versteegh, M.I., van Geuns, R.J., et al. Heart disease in The Netherlands: a quantitative update. Neth Heart J 22 (2014), 3–10.
2. [2] Niemeijer, M.N., van den Berg, M.E., Leening, M.J., Hofman, A., Franco, O.H., Deckers, J.W., et al. Declining incidence of sudden cardiac death from 1990–2010 in a general middle-aged and elderly population: the Rotterdam study. Heart Rhythm 12 (2015), 123–129.
3. [3] Nichols, M., Townsend, N., Scarborough, P., Rayner, M., Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980–2009. Eur Heart J 34 (2013), 3017–3027.
4. [4] Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2095–2128.
5. [5] Myerburg, R.J., Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol 12 (2001), 369–381.
6. [6] Wellens, H.J., Schwartz, P.J., Lindemans, F.W., Buxton, A.E., Goldberger, J.J., Hohnloser, S.H., et al. Risk stratification for sudden cardiac death: current status and challenges for the future. Eur Heart J 35 (2014), 1642–1651.
7. [7] Fox, C.S., Evans, J.C., Larson, M.G., Kannel, W.B., Levy, D., Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham heart study. Circulation 110 (2004), 522–527.
8. [8] Zipes, D.P., Wellens, H.J., Sudden cardiac death. Circulation 98 (1998), 2334–2351.
9. [9] Girotra, S., Nallamothu, B.K., Spertus, J.A., Li, Y., Krumholz, H.M., Chan, P.S., Trends in survival after in-hospital cardiac arrest. N Engl J Med 367 (2012), 1912–1920.
10. [10] Mitrani, R.D., Myerburg, R.J., Ten advances defining sudden cardiac death. Trends Cardiovasc Med 26 (2016), 23–33.
11. [11] de Vreede-Swagemakers, J.J., Gorgels, A.P., Dubois-Arbouw, W.I., van Ree, J.W., Daemen, M.J., Houben, L.G., et al. Out-of-hospital cardiac arrest in the 1990׳s: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 30 (1997), 1500–1505.
12. [12] Gulati, A., Jabbour, A., Ismail, T.F., Guha, K., Khwaja, J., Raza, S., et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. J Am Med Assoc 309 (2013), 896–908.
13. [13] Darpo, B., Nebout, T., Sager, P.T., Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the international conference on harmonization of technical requirements for registration of pharmaceuticals for human use E14 guideline. J Clin Pharmacol 46 (2006), 498–507.
14. [14] Vestbo, J., Hurd, S.S., Agusti, A.G., Jones, P.W., Vogelmeier, C., Anzueto, A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187 (2013), 347–365.
15. [15] Kurl, S., Jae, S.Y., Kauhanen, J., Ronkainen, K., Laukkanen, J.A., Impaired pulmonary function is a risk predictor for sudden cardiac death in men. Ann Med 47 (2015), 381–385.
16. [16] Agusti, A., Edwards, L.D., Rennard, S.I., MacNee, W., Tal-Singer, R., Miller, B.E., et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One, 7, 2012, e37483.
17. [17] Sin, D.D., Man, S.F., Impaired lung function and serum leptin in men and women with normal body weight: a population based study. Thorax 58 (2003), 695–698.
18. [18] Rodman, D.M., Lowenstein, S.R., Rodman, T., The electrocardiogram in chronic obstructive pulmonary disease. J Emerg Med 8 (1990), 607–615.
19. [19] Huiart, L., Ernst, P., Suissa, S., Cardiovascular morbidity and mortality in COPD. Chest 128 (2005), 2640–2646.
20. [20] Straus, S.M., Kors, J.A., De Bruin, M.L., van der Hooft, C.S., Hofman, A., Heeringa, J., et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 47 (2006), 362–367.
21. [21] Zulli, R., Donati, P., Nicosia, F., De Vecchi, M., Tantucci, C., Romanelli, G., et al. Increased QT dispersion: a negative prognostic finding in chronic obstructive pulmonary disease. Intern Emerg Med 1 (2006), 279–286.
22. [22] Tukek, T., Yildiz, P., Atilgan, D., Tuzcu, V., Eren, M., Erk, O., et al. Effect of diurnal variability of heart rate on development of arrhythmia in patients with chronic obstructive pulmonary disease. Int J Cardiol 88 (2003), 199–206.
23. [23] Sievi, N.A., Clarenbach, C.F., Camen, G., Rossi, V.A., van Gestel, A.J., Kohler, M., High prevalence of altered cardiac repolarization in patients with COPD. BMC Pulm Med, 14, 2014, 55.
24. [24] Lahousse, L., Niemeijer, M.N., van den Berg, M.E., Rijnbeek, P.R., Joos, G.F., Hofman, A., et al. Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study. Eur Heart J 36 (2015), 1754–1761.
25. [25] Zupanic, E., Zivanovic, I., Kalisnik, J.M., Avbelj, V., Lainscak, M., The effect of 4-week rehabilitation on heart rate variability and QTc interval in patients with chronic obstructive pulmonary disease. COPD 11 (2014), 659–669.
26. [26] Yildiz, P., Tukek, T., Akkaya, V., Sozen, A.B., Yildiz, A., Korkut, F., et al. Ventricular arrhythmias in patients with COPD are associated with QT dispersion. Chest 122 (2002), 2055–2061.
27. [27] Gaita, F., Giustetto, C., Bianchi, F., Wolpert, C., Schimpf, R., Riccardi, R., et al. Short QT Syndrome: a familial cause of sudden death. Circulation 108 (2003), 965–970.
28. [28] Iribarren, C., Round, A.D., Peng, J.A., Lu, M., Klatsky, A.L., Zaroff, J.G., et al. Short QT in a cohort of 1.7 million persons: prevalence, correlates, and prognosis. Ann Noninvasive Electrocardiol 19 (2014), 490–500.
29. [29] Makikallio, T.H., Barthel, P., Schneider, R., Bauer, A., Tapanainen, J.M., Tulppo, M.P., et al. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J 26 (2005), 762–769.
30. [30] Stewart, A.G., Waterhouse, J.C., Howard, P., The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD. Respir Med 89 (1995), 79–84.
31. [31] Kors, J.A., van Herpen, G., van Bemmel, J.H., QT dispersion as an attribute of T-loop morphology. Circulation 99 (1999), 1458–1463.
32. [32] Rautaharju, P.M., Dispersion in electrocardiography has become epidemic. Am J Cardiol, 86, 2000, 370.
33. [33] Hudson, L.D., Kurt, T.L., Petty, T.L., Genton, E., Arrhythmias associated with acute respiratory failure in patients with chronic airway obstruction. Chest 63 (1973), 661–665.
34. [34] Engdahl, J., Bang, A., Karlson, B.W., Lindqvist, J., Herlitz, J., Characteristics and outcome among patients suffering from out of hospital cardiac arrest of non-cardiac aetiology. Resuscitation 57 (2003), 33–41.
35. [35] Konecny, T., Park, J.Y., Somers, K.R., Konecny, D., Orban, M., Soucek, F., et al. Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias. Am J Cardiol 114 (2014), 272–277.
36. [36] Al-Khatib, S.M., Granger, C.B., Huang, Y., Lee, K.L., Califf, R.M., Simoons, M.L., et al. Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. Circulation 106 (2002), 309–312.
37. [37] Blom, M.T., Warnier, M.J., Bardai, A., Berdowski, J., Koster, R.W., Souverein, P.C., et al. Reduced in-hospital survival rates of out-of-hospital cardiac arrest victims with obstructive pulmonary disease. Resuscitation 84 (2013), 569–574.
38. [38] McGarvey, L.P., Magder, S., Burkhart, D., Kesten, S., Liu, D., Manuel, R.C., et al. Cause-specific mortality adjudication in the UPLIFT(R) COPD trial: findings and recommendations. Respir Med 106 (2012), 515–521.
39. [39] Wang, H., Lei, W., Li, Y., Xu, T., The epidemiology of non-traumatic prehospital sudden death in Macau. Resuscitation 74 (2007), 222–226.
40. [40] Nishiyama, K., Shizuta, S., Doi, T., Morimoto, T., Kimura, T., Sudden cardiac death after PCI and CABG in the bare-metal stent era: incidence, prevalence, and predictors. Int J Cardiol 144 (2010), 263–266.
41. [41] Ozcan, C., Jahangir, A., Friedman, P.A., Hayes, D.L., Munger, T.M., Rea, R.F., et al. Sudden death after radiofrequency ablation of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol 40 (2002), 105–110.
42. [42] Urena, M., Webb, J.G., Eltchaninoff, H., Munoz-Garcia, A.J., Bouleti, C., Tamburino, C., et al. Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death. J Am Coll Cardiol 65 (2015), 437–448.
43. [43] Naksuk, N., Kunisaki, K.M., Benditt, D.G., Tholakanahalli, V., Adabag, S., Implantable cardioverter-defibrillators in patients with COPD. Chest 144 (2013), 778–783.
44. [44] Dougherty, C.M., Hunziker, J., Predictors of implantable cardioverter defibrillator shocks during the first year. J Cardiovasc Nurs 24 (2009), 21–28 [quiz 29–30].
45. [45] Warnier, M.J., Blom, M.T., Bardai, A., Berdowksi, J., Souverein, P.C., Hoes, A.W., et al. Increased risk of sudden cardiac arrest in obstructive pulmonary disease: a case–control study. PLoS One, 8, 2013, e65638.
46. [46] Uchmanowicz, I., Bartkiewicz, W., Sowizdraniuk, J., Rosinczuk, J., Factors affecting the occurrence of out-of-hospital sudden cardiac arrest. Emerg Med Int, 2015, 2015, 281364.
47. [47] Shih, H.T., Webb, C.R., Conway, W.A., Peterson, E., Tilley, B., Goldstein, S., Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest 94 (1988), 44–48.
48. [48] Chugh, S.S., Uy-Evanado, A., Teodorescu, C., Reinier, K., Mariani, R., Gunson, K., et al. Women have a lower prevalence of structural heart disease as a precursor to sudden cardiac arrest: the Ore-SUDS (Oregon sudden unexpected death study). J Am Coll Cardiol 54 (2009), 2006–2011.
49. [49] Abrignani, M.G., Dominguez, L.J., Biondo, G., Di Girolamo, A., Novo, G., Barbagallo, M., et al. In-hospital complications of acute myocardial infarction in hypertensive subjects. Am J Hypertens 18 (2005), 165–170.
50. [50] Tirlapur, V.G., Mir, M.A., Nocturnal hypoxemia and associated electrocardiographic changes in patients with chronic obstructive airways disease. N Engl J Med 306 (1982), 125–130.
51. [51] Agusti, A., Hedner, J., Marin, J.M., Barbe, F., Cazzola, M., Rennard, S., Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev 20 (2011), 183–194.
52. [52] MacDonald, M.I., Shafuddin, E., King, P.T., Chang, C.L., Bardin, P.G., Hancox, R.J., Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease. Lancet Respir Med 4 (2016), 138–148.
53. [53] Celli, B., Decramer, M., Leimer, I., Vogel, U., Kesten, S., Tashkin, D.P., Cardiovascular safety of tiotropium in patients with COPD. Chest 137 (2010), 20–30.
54. [54] Lahousse, L., Verhamme, K.M., Stricker, B.H., Brusselle, G.G., Cardiac effects of current treatments of chronic obstructive pulmonary disease. Lancet Respir Med 4 (2016), 149–164.
55. [55] Patakas, D., Louridas, G., Kakavelas, E., Reduced baroreceptor sensitivity in patients with chronic obstructive pulmonary disease. Thorax 37 (1982), 292–295.
56. [56] Volterrani, M., Scalvini, S., Mazzuero, G., Lanfranchi, P., Colombo, R., Clark, A.L., et al. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest 106 (1994), 1432–1437.
57. [57] Heindl, S., Lehnert, M., Criee, C.P., Hasenfuss, G., Andreas, S., Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 164 (2001), 597–601.
58. [58] Niemeijer, M.N., van den Berg, M.E., Eijgelsheim, M., van Herpen, G., Stricker, B.H., Kors, J.A., et al. Short-term QT variability markers for the prediction of ventricular arrhythmias and sudden cardiac death: a systematic review. Heart 100 (2014), 1831–1836.
59. [59] de Miguel Diez, J., Chancafe Morgan, J., Jimenez Garcia, R., The association between COPD and heart failure risk: a review. Int J Chron Obstruct Pulmon Dis 8 (2013), 305–312.
60. [60] Wise, R., Calverley, P.M., Dahl, R., Dusser, D., Metzdorf, N., Muller, A., et al. Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial. NPJ Prim Care Respir Med, 25, 2015, 15067.
61. [61] Vestbo, J., Anderson, J., Brook, R.D., Calverley, P.M., Celli, B.R., Crim, C., et al. The study to understand mortality and morbidity in COPD (SUMMIT) study protocol. Eur Respir J 41 (2013), 1017–1022.
62. [62] van Noord, C., Eijgelsheim, M., Stricker, B.H., Drug- and non-drug-associated QT interval prolongation. Br J Clin Pharmacol 70 (2010), 16–23.
63. [63] Perera, W.R., Hurst, J.R., Wilkinson, T.M., Sapsford, R.J., Mullerova, H., Donaldson, G.C., et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 29 (2007), 527–534.
64. [64] Whyte, K.F., Addis, G.J., Whitesmith, R., Reid, J.L., Adrenergic control of plasma magnesium in man. Clin Sci (Lond) 72 (1987), 135–138.
65. [65] Kieboom, B.C., Niemeijer, M.N., Leening, M.J., van den Berg, M.E., Franco, O.H., Deckers, J.W., et al. Serum magnesium and the risk of death from coronary heart disease and sudden cardiac death. J Am Heart Assoc, 2016, 5.